Location History:
- Frechen-Bachem, DE (1986 - 1989)
- Hurth, DE (1992)
- Viry Chatillon, FR (1995)
Company Filing History:
Years Active: 1986-1995
Title: Norbert Dereu: A Pioneer in Pharmaceutical Innovations
Introduction
Norbert Dereu, an accomplished inventor based in Frechen-Bachem, Germany, has made significant contributions to the field of pharmaceuticals through his innovative research and patenting activities. With a total of six patents to his name, Dereu's work showcases his dedication to developing new compounds that have the potential to improve health outcomes.
Latest Patents
Dereu's latest patents include groundbreaking research on lupane derivatives and their preparation for pharmaceutical use. One of his notable patents relates to new lupane derivatives of a general formula, focusing on their salts and pharmaceutical compositions. Additionally, he has developed anti-inflammatory picolyselenobenzamides, which have been disclosed as compounds with anti-inflammatory activity, thereby showing promise in therapeutic applications.
Career Highlights
Throughout his career, Norbert Dereu has worked with esteemed companies, including A. Nattermann & Cie GmbH and Rhone-Poulenc Rorer S.A. These experiences have undoubtedly shaped his approach to innovation in pharmaceuticals and contributed to his successful patent portfolio.
Collaborations
Dereu’s collaborations with renowned professionals in the field, such as Andre Welter and Albrecht Wendel, have also been instrumental in advancing his research. Working alongside such talented individuals has helped him refine his inventions and enhance their applicability in the pharmaceutical industry.
Conclusion
Norbert Dereu's impact on the pharmaceutical sector is evident through his innovative solutions and patent contributions. His work with lupane derivatives and anti-inflammatory compounds continues to inspire advancements in drug development, paving the way for future innovations in healthcare. As he continues to push the boundaries of research, the potential benefits of his discoveries may significantly improve patient outcomes in the years to come.